Skip to content
The Nexus
DossierENTITY

GENB

Coverage of GENB in the Nexus archive.

Earliest in view: Aug 6 · 10:24 UTCMost recent: Aug 6 · 10:24 UTC
Co-mentioned in this coverage
Generate Biomedicines Inc.organization1Somervilleplace1Zacks Investment Researchorganization1
Recent coverage
  • BUSINESSAug 6 · 10:24 UTCWTOP DC
    Generate Biomedicines: Q2 Earnings Snapshot

    Generate Biomedicines Inc. reported a loss of $67.3 million and 52 cents per share in its second quarter, missing Wall Street expectations. The company also posted revenue of $6.3 million, which missed Street forecasts.

GENB · Dossier · The Nexus